Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods
US-2016320338-A1 · Nov 3, 2016 · US
US9599543B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9599543-B2 |
| Application number | US-201514938780-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 11, 2015 |
| Priority date | Sep 20, 2011 |
| Publication date | Mar 21, 2017 |
| Grant date | Mar 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Solid beads each containing a selected quantity of analyte are combined and a liquid base matrix that contains attributes of a biological fluid that is to be assayed, together constitute a kit from which a laboratory technician can, at the point of use, prepare a liquid control for a particular analyte, and preferably a series of such controls at different levels of the same analyte customized for a particular assay.
Opening claim text (preview).
What is claimed is: 1. A kit for preparation of a customized control for a diagnostic assay, said kit comprising: an aqueous liquid matrix comprising a salt and a buffer at a pH of from about 4.0 to about 9.0, wherein the aqueous liquid matrix comprises human or animal source materials from which endogenous species that interfere with the detection of said one or more selected analyte have been removed; and a plurality of solid water-soluble beads, wherein the solid water-soluble beads are prepared by lyophilization of an aqueous solution ranging in volume from about 5 μL to about 1,000 μL, and the solid water-soluble beads comprise at least one analyte, a bulking agent, a salt, and a buffer, wherein said beads are configured for 1) dissolving different quantities of the one or more solid water-soluble bead in separate aliquots of said aqueous liquid matrix, wherein the aliquots have equal volume; or 2) dissolving the same quantities of the one or more solid water-soluble bead in separate aliquots of said aqueous liquid matrix, wherein the aliquots have different volume. 2. The kit of claim 1 wherein said solid water-soluble beads consist essentially of one analyte, said bulking agent, said salt, and said buffer. 3. The kit of claim 1 wherein said kit comprising a plurality of distinct water-soluble beads, each distinct bead containing an analyte. 4. The kit of claim 1 wherein said assay is an assay of a plurality of distinct selected analytes, and each said water-soluble bead contains all of said analytes. 5. The kit of claim 1 wherein said aqueous liquid matrix further comprises a stabilizer selected from the group consisting of a protease inhibitor, a chelating agent, a crosslinking agent, a cryoprotectant, a reducing agent, and a surfactant. 6. The kit of claim 1 wherein said aqueous liquid matrix further comprises an antimicrobial agent selected from the group consisting of sodium azide, ciprofloxacin chloramphenicol, gentamicin, amikacin, tobramycin, and amphotericin B. 7. The kit of claim 1 wherein said aqueous liquid matrix has a pH of from about 6.2 to about 8.5. 8. The kit of claim 1 wherein said aqueous liquid matrix has an osmolarity of from about 50 to about 1,000 mOsm/kg. 9. The kit of claim 1 wherein each said water-soluble bead is substantially spherical with a diameter of from about 3 mm to about 10 mm. 10. The kit of claim 3 wherein at least one distinct water-soluble bead contains two or more analytes. 11. The kit of claim 1 wherein said human or animal source materials comprise a human biological fluid. 12. The kit of claim 1 wherein the aqueous liquid matrix comprises albumin. 13. The kit of claim 1 , wherein the human or animal source materials is selected from the group consisting of whole blood, plasma, serum, urine, oral fluid, and synovial fluid. 14. The kit of claim 1 , wherein the kit further comprises two or more aliquots of the aqueous liquid matrix having equal volume. 15. The kit of claim 1 , wherein the kit further comprises two or more aliquots of the aqueous liquid matrix having different volume. 16. The kit of claim 12 wherein said albumin is selected from the group consisting of human serum albumin and bovine serum albumin.
Multi-analyte reference solutions containing cholesterol, glucose and the like · CPC title
Serum albumin, e.g. HSA · CPC title
involving blood or serum control standard · CPC title
involving dehydrogenase · CPC title
Reference solutions for assays of biological material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.